Karachi: The Searle Company Limited has reported significant financial growth for the fiscal year ending June 30, 2026, according to its recently released annual report. The report, dated October 5, 2026, highlights a robust increase in both assets and profits, reflecting the company's strong market performance.
The company's unconsolidated statement of financial position reveals total assets of 49.78 billion rupees, an increase from 44.68 billion rupees in 2025. This growth is largely attributed to a rise in non-current assets, particularly long-term investments in subsidiaries, which surged to 12.35 billion rupees from 9.67 billion rupees. Current assets also saw an uptick, with inventories climbing to 5.23 billion rupees from 3.72 billion rupees.
Equity for The Searle Company Limited has increased to 34.80 billion rupees from 30.24 billion rupees the previous year. This rise was supported by an increase in unappropriated profit, which reached 14.68 billion rupees compared to 11.18 billion rupees in 2025. The issued, subscribed, and paid-up capital also rose to 5.88 billion rupees from 5.11 billion rupees.
According to information available from the Pakistan Stock Exchange (PSX), the company's revenue from contracts with customers exhibited a very large move, increasing to 31.64 billion rupees, up from 24.77 billion rupees in the prior year. The gross profit reported was 16.75 billion rupees, compared to 12.59 billion rupees in 2025. The profit from operations climbed to 7.92 billion rupees from 2.76 billion rupees, indicating a substantial enhancement in operational efficiency.
The profit before income tax for the company experienced a very large move, rising to 6.85 billion rupees from 726.32 million rupees. After accounting for an income tax expense of 2.84 billion rupees, the profit for the year stood at 4.00 billion rupees, a significant improvement from the previous year's 434.04 million rupees.
The report also details a total comprehensive income for the year of 4.56 billion rupees, compared to 1.14 billion rupees in 2025. Basic and diluted earnings per share increased significantly to 6.81 rupees from 0.74 rupees.
The data from the annual report indicates The Searle Company Limited's continued growth and its impact on the pharmaceutical sector within the designated market category. The company's strategic investments and operational efficiencies appear to have played a crucial role in its enhanced financial performance.